Lumos Diagnostics Holdings Limited LDXHF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 31.06% | -16.81% | -85.81% | -21.12% | 16.40% |
| Total Depreciation and Amortization | 1.31% | -6.04% | -12.75% | -9.55% | -6.27% |
| Total Amortization of Deferred Charges | -0.47% | -23.07% | -37.25% | -37.25% | -37.25% |
| Total Other Non-Cash Items | -245.19% | 361.47% | 340.50% | 439.15% | -24.14% |
| Change in Net Operating Assets | 183.03% | -4,086.36% | -200.41% | -200.41% | -200.41% |
| Cash from Operations | 110.86% | 87.43% | -326.09% | -2,878.90% | -1,086.68% |
| Capital Expenditure | -4,688.68% | -2,342.48% | -270.00% | -145.54% | -1.92% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4,688.68% | -1,740.00% | -128.87% | -41.03% | 45.92% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -83.19% | -40.33% | -0.49% | 41.87% | 60.07% |
| Issuance of Common Stock | 199.13% | 57.31% | -84.51% | -37.91% | 16.26% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -762.32% | -- | -- | -- |
| Cash from Financing | 188.65% | 44.75% | -101.13% | -33.41% | 100.61% |
| Foreign Exchange rate Adjustments | 43.69% | 71.92% | 99.29% | 5.47% | -2,842.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 397.88% | 3,055.41% | -161.11% | -192.70% | -230.57% |